Access cutting-edge chronic spontaneous urticaria treatment through this clinical trial at a research site in Boise. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Boise location
Access chronic spontaneous urticaria specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic spontaneous urticaria treatment provided free
Check if you qualify for this chronic spontaneous urticaria clinical trial in Boise, ID
No-Cost Study Care
Local to Boise
Convenient for ID residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This trial will be performed as a three-part dose escalating clinical trial where Parts 1 is open label and Parts 2 and 3 are randomized, double-blinded, and placebo-controlled. The trial is intended to determine the safety and tolerability and assess the preliminary efficacy of briquilimab in adult participants with chronic spontaneous urticaria (CSU), who remain symptomatic despite treatment with H1 antihistamines and omalizumab. Additionally, pharmacokinetic (PK) properties of briquilimab, a
Sponsor: Jasper Therapeutics, Inc.
Yes, this clinical trial (NCT06162728) has an active research site in Boise, ID that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for chronic spontaneous urticaria treatment options in Boise, ID, this clinical trial (NCT06162728) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boise research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic spontaneous urticaria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all chronic spontaneous urticaria clinical trials near you to find additional studies recruiting in your area.
See all chronic urticaria clinical trials recruiting in Boise — not just this study.
Browse Chronic Urticaria Trials in Boise →